Menu
Back to Journals » Drug Design, Development and Therapy » Volume 14
Original Research
The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,136 | Dovepress* | 6,442+ | 1,016 | 7,458 | |
| PubMed Central* | 694 | 362 | 1,056 | ||
| Totals | 7,136 | 1,378 | 8,514 | ||
| *Since 31 July 2020 | |||||
View citations on PubMed and Google Scholar